ArticlePharmacotherapy2017

Application of a Risk Score to Identify Older Adults with Community-Onset Pneumonia Most Likely to Benefit From Empiric Pseudomonas Therapy.

Christopher R Frei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.